Clovis Oncology Inc. (NASDAQ:CLVS) Reports Q3 2020 Results With Rubraca Sales...

Max - 0

Oncternal Therapeutics Inc. (NASDAQ:ONCT) Provides Updates On Cirmtuzumab In Combination With...

Max - 0

Amarin Corporation plc (NASDAQ:AMRN) Announces Q3 Results As VASCEPA Continues To...

Max - 0

Akebia Therapeutics Inc. (NASDAQ:AKBA) Announces Q3 Results And Updates About Pre-NDA...

Max - 0

The Virus Testing Stocks Pullback Opportunity (CODX, FLGT, ALST, LH)

Max - 0

CRISPR Therapeutics (NASDAQ:CRSP) And Vertex Pharmaceuticals (NASDAQ:VRTX) To Present More Data...

Max - 0

Kura Oncology Inc. (NASDAQ:KURA) Reports Q3 2020 Results And Announces Presentation...

Max - 0

Allogene Therapeutics Inc. (NASDAQ:ALLO) To Present Preliminary Data From ALLO-715 Study...

Max - 0

Outlook Therapeutics Inc. (NASDAQ:OTLK) Secures $10 Million Funding To Support BLA...

Max - 0

Cassava Sciences Inc. (NASDAQ:SAVA) Released Addition Phase 2b Clinical Study Results...

Max - 0
1...167168169...248Page 168 of 248